WO2001087255A1 - External application for enhancing the skin permeability of the active components therein - Google Patents
External application for enhancing the skin permeability of the active components therein Download PDFInfo
- Publication number
- WO2001087255A1 WO2001087255A1 PCT/KR2001/000788 KR0100788W WO0187255A1 WO 2001087255 A1 WO2001087255 A1 WO 2001087255A1 KR 0100788 W KR0100788 W KR 0100788W WO 0187255 A1 WO0187255 A1 WO 0187255A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- composition
- absoφtion
- external application
- linkage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Definitions
- the present invention relates to an external application for enhancing the skin absorbency of the active agent infused therein, more specifically, relates to an external application having enhanced skin absorbency of the active agents by using protease stabilized by ⁇ -l,3-glucan branched with ⁇ -l,6-linkage as an agent for enhancing the skin abso ⁇ tion.
- Skin is divided into three portions, a stratum corneum, epidermal layer and dermis, and the most important barrier for skin absorption of the active agent contained in the external application such as cosmetics is the stratum corneum located on the outermost portion.
- the stratum corneum is composed of corneous cell mainly comprising keratins and lipid layer filling the space between corneous cells, liposoluble active agents are well absorbed into the skin while water- soluble agents and large-molecule agents are not. Therefore, most of the agents infused in the external applications such as cosmetics are not easily absorbed into the skin, because they are water-soluble.
- some patents teach other methods for enhancing the skin abso ⁇ tion of the active agents by modifying or weakening the skin barrier function with enzyme.
- U.S. Patent Nos. 5,534,260 and 5,296,222 show methods for enhancing the abso ⁇ tion of the active agents by adding protease.
- the above methods are just adding protease into the composition, and therefore, the protease is degenerated or loses its activity with time by the effects of other elements infused in the formulation.
- the enzyme active agent
- the above methods are not suitable for external application comprising a lot of elements in addition to the active agent.
- inventors of the present invention searched for a method for enhancing the skin abso ⁇ tion of the active agents infused in the external application such as cosmetics, and finally found that when protease stabilized by ⁇ -l,3-glucan branched with ⁇ -l,6-linkage is used as an agent for enhancing the skin abso ⁇ tion in the external application, the abso ⁇ tion rate is increased.
- an object of the present invention is to provide a composition for external application to the skin having the properties of enhanced skin absorbency of the active agents infused in the composition.
- the present invention provides a composition for external skin application with enhanced skin abso ⁇ tion properties by using protease stabilized by ⁇ -l,3-glucan branched with ⁇ -l,6-linkage as skin abso ⁇ tion enhancing agent in the skin external application.
- Said composition enhances the skin abso ⁇ tion by modifying the structure of the corneous layer or removing the layer without causing skin stimulus.
- a method for preparing the protease used as a skin abso ⁇ tion enhancing agent of the present composition complies with the method described in KR 2000-60771 Al (published on Oct. 16, 2000) entitled "Method for preparing stabilized enzyme or protein, and composition for external application comprising the stabilized enzyme or protein provided by the method".
- the method for stabilizing the protease comprises the steps of; (1) reacting a glucan with periodates to transform the ⁇ -l,6-linkage of the glucan into aldehyde; (2) removing unreacted periodates from the reaction solution of step (1); (3) adding a protease to the reaction solution of step (2) in an amount of 0.00001 ⁇ 10.0% by weight; (4) adding a reducing agent to the reaction solution of step (3) in an amount of 0.0001 ⁇ 1.0% by weight; and (5) washing the product of step (4).
- Glucans used in the above method are ⁇ -l,3-glucans branched with ⁇ - 1,6-linkage, and the glucans can make functional groups only in the ⁇ -1,6- linkage depending on the chemical reaction.
- Glucans used in the present invention are not restricted, preferably schizophyllan derived from Schizopyllum commune, scleroglucan derived from Sclerotinia sp. and lentinan derived from Lentinus edodes are used.
- proteases stabilized by the method of the present invention are not restricted, preferably papain, chymotrypsin, trypsin, carboxypepidase, pepsin, et al. are used.
- the amount of the stabilized protease contained in the composition of the external application is 0.0001 ⁇ 99.9999 % by weight on the basis of the weight of total composition.
- formulation for external application is not restricted.
- they may have cosmetic formulation such as skin softener, nutrition water, massage cream, make-up base, lipstick, pack, gel, shampoo, rinse, hair tonic or soap, or external dermatological formulation such as lotion, ointment, gel, cream, patch or spray.
- the sorts of active agents having their skin abso ⁇ tion properties enhanced by the skin abso ⁇ tion enhancers of the present invention are conventional active agents, and are not restricted specifically.
- water-soluble derivatives of L-ascorbic acid such as L-ascorbic acid, L-ascorbic phosphate, L-ascorbic glucoside, et al., vitamin B, kojic acid, kojic caffeine acid, kojic aminopropyl phosphate, hydroquinone, albutine, water soluble natural extract derived from green tea or grape by water or ethanol, et al. are used as active agents.
- step 4) Ingredient 8 was added to the solution of step 3) to form a gel. 5) Gas bubbles were removed by vacuum deaeration, then a water-gel type cosmestic was obtained.
- the amount of the ascorbic acid absorbed into the skin was measured with the method described in Experimental Example 1 except that water-in-oil type cosmetic composition of Example 2 and Comparative Example 3 were used. The results are shown in Table 2.
- Table 2 shows that when a stabilized protease is added to the composition, the skin abso ⁇ tion of ascorbic acid is increased by about six times compared with a case that a stabilized protease is not added.
- A(ingredients 1-9 and ingredient 17) and B (ingredients 10-12) were heated to 75 °C.
- the amount of the hydroquinone absorbed into the skin was measured with the method described in Experimental Example 1 except that ointments prepared in the Example 3 and Comparative Example 5 were used. The results are shown in Table 3.
- Table 3 shows that when a stabilized protease is added to the composition, the skin abso ⁇ tion of hydroquinone is increased by about six times compared with a case that a stabilized protease is not added.
- the amount of the kojic acid absorbed into the skin was measured with the method described in Experimental Example 1 except that aqueous gel type cosmetic compositions of Example 1 and Comparative Example 2 after 30 days of their preparation were used. The results are shown in Table 4.
- Table 4 shows that although papain is contained in the cosmetic composition, as shown in case of comparative example 2 that do not comprise stabilized papain, papain loses its activity after 30 days of its preparation by the effects of the other ingredients contained together, therefore papain no longer shows the skin abso ⁇ tion enhancement.
- Experimental Example 5 Measurement for skin abso ⁇ tion of the ascorbic acid infused in the water-in-oil cosmetic composition after 30 days of its preparation The amount of the ascorbic acid absorbed into the skin was measured with the method described in Experimental Example 2 except that water-in-oil type cosmetic compositions of Example 2 and Comparative Example 4 after 30 days of their preparation were used. The results are shown in Table 5.
- Table 5 shows that although papain is contained in the cosmetic composition, as shown in the case of comparative example 4 that does not comprise stabilized papain, papain loses its activity after 30 days of its preparation by the effects of the other ingredients contained together, therefore papain no longer shows the skin abso ⁇ tion enhancement.
- Table 6 shows that although papain is contained in the cosmetic composition, as shown in case of comparative example 6 that does not comprise stabilized papain, papain loses its activity after 30 days of its preparation by the effects of the other ingredients contained together, therefore papain no longer shows the skin abso ⁇ tion enhancement.
- the skin abso ⁇ tion enhancers of the present invention do not cause skin problems such as skin stimuli, skin injury, et al., but the do enhance the skin abso ⁇ tion of the components that have problems in permeation because of they have low affinity to the corneous layer or high molecular weight.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01932343A EP1282393B1 (en) | 2000-05-16 | 2001-05-16 | External application for enhancing the skin permeability of the active components therein |
DE60114801T DE60114801T2 (en) | 2000-05-16 | 2001-05-16 | PREPARATION FOR EXTERNAL USE TO IMPROVE THE PERMEABILITY OF THE SKIN FOR ACTIVE SUBSTANCES |
AU2001258876A AU2001258876A1 (en) | 2000-05-16 | 2001-05-16 | External application for enhancing the skin permeability of the active components therein |
JP2001583724A JP5013648B2 (en) | 2000-05-16 | 2001-05-16 | Composition for enhancing skin absorption of active ingredient in external preparation for skin |
AT01932343T ATE308967T1 (en) | 2000-05-16 | 2001-05-16 | PREPARATION FOR EXTERNAL USE TO IMPROVE THE PERMEABILITY OF THE SKIN TO ACTIVE INGREDIENTS |
US10/276,176 US20040022753A1 (en) | 2000-05-16 | 2001-05-16 | External application for enhancing the skin permeability of the active components therein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000026086A KR100338327B1 (en) | 2000-05-16 | 2000-05-16 | External application for enhancing the skin permeability of the active components therein |
KR2000/26086 | 2000-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001087255A1 true WO2001087255A1 (en) | 2001-11-22 |
Family
ID=19668725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2001/000788 WO2001087255A1 (en) | 2000-05-16 | 2001-05-16 | External application for enhancing the skin permeability of the active components therein |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040022753A1 (en) |
EP (1) | EP1282393B1 (en) |
JP (1) | JP5013648B2 (en) |
KR (1) | KR100338327B1 (en) |
CN (1) | CN1457253A (en) |
AT (1) | ATE308967T1 (en) |
AU (1) | AU2001258876A1 (en) |
DE (1) | DE60114801T2 (en) |
WO (1) | WO2001087255A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100338327B1 (en) * | 2000-05-16 | 2002-08-07 | 주식회사 태평양 | External application for enhancing the skin permeability of the active components therein |
WO2003047629A2 (en) * | 2001-11-29 | 2003-06-12 | Molecular Skincare Limited | Treatment of diseases via the skin |
WO2006015627A1 (en) * | 2004-08-13 | 2006-02-16 | Symrise Gmbh & Co. Kg | β-(1,3)-β-(1,4)-GLUCAN AS CARRIER FOR CHEMICAL SUBSTANCES |
EP1720605A2 (en) * | 2003-06-23 | 2006-11-15 | Transpharma Medical Ltd. | Transdermal delivery system for cosmetic agents |
WO2010105842A2 (en) | 2009-03-19 | 2010-09-23 | Bubbles And Beyond Gmbh | Preparation for external application |
WO2011061144A2 (en) | 2009-11-20 | 2011-05-26 | Basf Se | The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100447055B1 (en) * | 2001-07-30 | 2004-09-04 | 주식회사 참 존 | Technical procedure of modified Alternan production and enzyme stabilization |
KR20030082765A (en) * | 2002-04-18 | 2003-10-23 | 한국화학연구원 | Transdermal drug delivery matrix type system contained hydroquinone and cosmetic ingredients |
KR100507960B1 (en) * | 2002-10-22 | 2005-08-19 | (주)나노팜 | Composition of removing corneum, method of preparing the same and cleansing composition including the same |
JP4626202B2 (en) * | 2003-07-16 | 2011-02-02 | 大正製薬株式会社 | Piroxicam-containing external anti-inflammatory analgesic composition |
DE102004010940B4 (en) | 2004-03-05 | 2012-01-26 | Erbe Elektromedizin Gmbh | Neutral electrode for HF surgery |
EP1609460A1 (en) * | 2004-06-24 | 2005-12-28 | The Procter & Gamble Company | Skin care compositions comprising fatty material having a melting temperature range of 21-40 C |
EP1824499A2 (en) * | 2004-12-10 | 2007-08-29 | Alcon Inc. | Compositions for treatment of ear infections |
WO2007119467A1 (en) * | 2006-03-23 | 2007-10-25 | Cosmed Pharmaceutical Co., Ltd. | Percutaneous absorption promoting agent and percutaneous absorption preparation using the same |
US20080160043A1 (en) * | 2007-07-16 | 2008-07-03 | Kim Moo-Sung | Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03209333A (en) * | 1990-01-10 | 1991-09-12 | Nippon Chem Res Kk | Agent for suppressing proliferation of herpes virus and inhibiting relapse after latent infection |
WO1999015210A2 (en) * | 1997-09-26 | 1999-04-01 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
KR20000060771A (en) * | 1999-03-19 | 2000-10-16 | 서경배 | A method for stabilizing enzymes or proteins and compositions for external application containing enzymes or proteins stabilized thereby |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61282313A (en) * | 1985-06-06 | 1986-12-12 | Nitto Electric Ind Co Ltd | Enzyme-containing plaster |
US5156846A (en) * | 1989-02-23 | 1992-10-20 | University Of Utah | Percutaneous drug delivery system |
JP3000488B2 (en) * | 1991-03-07 | 2000-01-17 | 株式会社コーセー | Cosmetics |
JPH06321733A (en) * | 1993-05-07 | 1994-11-22 | Noevir Co Ltd | Sheetlike pack agent and its production |
US5441740A (en) * | 1994-05-06 | 1995-08-15 | Longevity Network. Ltd. | Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain |
JPH09176029A (en) * | 1995-12-26 | 1997-07-08 | Shigenobu Sakata | Outer cortex function-stimulating and infection-preventing liquid and its production |
CN1244317C (en) * | 1996-08-02 | 2006-03-08 | 株式会社资生堂 | Composition for enhancing hyaluronic acid productivity and method for preparing same |
US6162419A (en) * | 1996-11-26 | 2000-12-19 | Nicholas V. Perricone | Stabilized ascorbyl compositions |
FR2761363B1 (en) * | 1997-03-28 | 1999-11-26 | Oreal | PURIFYING SKIN POLYPEPTIDE AND ITS USE |
FR2781668B1 (en) * | 1998-07-31 | 2001-06-01 | Oreal | SKIN TREATMENT PROCESS AND PATCH FOR IMPLEMENTING THE PROCESS |
KR100338327B1 (en) * | 2000-05-16 | 2002-08-07 | 주식회사 태평양 | External application for enhancing the skin permeability of the active components therein |
-
2000
- 2000-05-16 KR KR1020000026086A patent/KR100338327B1/en active IP Right Grant
-
2001
- 2001-05-16 EP EP01932343A patent/EP1282393B1/en not_active Expired - Lifetime
- 2001-05-16 DE DE60114801T patent/DE60114801T2/en not_active Expired - Lifetime
- 2001-05-16 US US10/276,176 patent/US20040022753A1/en not_active Abandoned
- 2001-05-16 CN CN01809165A patent/CN1457253A/en active Pending
- 2001-05-16 WO PCT/KR2001/000788 patent/WO2001087255A1/en active IP Right Grant
- 2001-05-16 JP JP2001583724A patent/JP5013648B2/en not_active Expired - Lifetime
- 2001-05-16 AT AT01932343T patent/ATE308967T1/en not_active IP Right Cessation
- 2001-05-16 AU AU2001258876A patent/AU2001258876A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03209333A (en) * | 1990-01-10 | 1991-09-12 | Nippon Chem Res Kk | Agent for suppressing proliferation of herpes virus and inhibiting relapse after latent infection |
WO1999015210A2 (en) * | 1997-09-26 | 1999-04-01 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
KR20000060771A (en) * | 1999-03-19 | 2000-10-16 | 서경배 | A method for stabilizing enzymes or proteins and compositions for external application containing enzymes or proteins stabilized thereby |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100338327B1 (en) * | 2000-05-16 | 2002-08-07 | 주식회사 태평양 | External application for enhancing the skin permeability of the active components therein |
WO2003047629A2 (en) * | 2001-11-29 | 2003-06-12 | Molecular Skincare Limited | Treatment of diseases via the skin |
WO2003047629A3 (en) * | 2001-11-29 | 2003-08-28 | Molecular Skincare Ltd | Treatment of diseases via the skin |
EP1720605A2 (en) * | 2003-06-23 | 2006-11-15 | Transpharma Medical Ltd. | Transdermal delivery system for cosmetic agents |
JP2007521258A (en) * | 2003-06-23 | 2007-08-02 | トランスファーマ メディカル リミテッド | Transdermal delivery system for cosmetics |
EP1720605A4 (en) * | 2003-06-23 | 2007-10-24 | Transpharma Medical Ltd | Transdermal delivery system for cosmetic agents |
WO2006015627A1 (en) * | 2004-08-13 | 2006-02-16 | Symrise Gmbh & Co. Kg | β-(1,3)-β-(1,4)-GLUCAN AS CARRIER FOR CHEMICAL SUBSTANCES |
WO2010105842A2 (en) | 2009-03-19 | 2010-09-23 | Bubbles And Beyond Gmbh | Preparation for external application |
DE102009013469A1 (en) | 2009-03-19 | 2010-12-09 | Bubbles And Beyond Gmbh | Preparation for external use |
WO2011061144A2 (en) | 2009-11-20 | 2011-05-26 | Basf Se | The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen |
Also Published As
Publication number | Publication date |
---|---|
DE60114801D1 (en) | 2005-12-15 |
DE60114801T2 (en) | 2006-11-23 |
EP1282393B1 (en) | 2005-11-09 |
JP2004507458A (en) | 2004-03-11 |
ATE308967T1 (en) | 2005-11-15 |
KR20010104881A (en) | 2001-11-28 |
CN1457253A (en) | 2003-11-19 |
KR100338327B1 (en) | 2002-08-07 |
EP1282393A1 (en) | 2003-02-12 |
JP5013648B2 (en) | 2012-08-29 |
AU2001258876A1 (en) | 2001-11-26 |
EP1282393A4 (en) | 2004-03-31 |
US20040022753A1 (en) | 2004-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2306040C (en) | Coloring agent-containing sunless tanning compositions | |
EP0686386B1 (en) | Cosmetic and dermatologic composition comprising a stable aqueous dispersion of phytantriol-based gel particles containing a long-chain surfactant as dispersant and stabilizer | |
EP1282393B1 (en) | External application for enhancing the skin permeability of the active components therein | |
EP0661035B1 (en) | Cosmetic composition for the simultaneous treatment of the superficial skinlayers and the deep skinlayers | |
EP0754449A1 (en) | Skin whitening composition and/or anti-aging composition and uses thereof | |
US20090130036A1 (en) | Self tanning product having slimming, firming and toning properties associated therewith | |
KR101840045B1 (en) | Liposomes encapsulating an oxazolidin-2-one compound | |
US6645508B1 (en) | Stable L-ascorbic acid composition | |
CN102933192A (en) | Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that transcur through a deficit of maturation of the cornified envelope | |
CN111743807A (en) | Water-oil insoluble transparent ceramide aqueous solution and preparation method thereof | |
KR20200137431A (en) | Composition for skin anti-inflammation and skin moisturizing comprising artemisia extract extracted with skin cosmetic solution as a solvent | |
KR102233140B1 (en) | Cosmetic composition for skin improvement containing low molecular weight hyaluronic acid | |
EP3777825A1 (en) | Composition of freeze-dried formulation, cosmetic kit for external use on skin including the same, and its use | |
KR101605324B1 (en) | Cosmetic composition for moisturizing skin which alleviates itchiness and dryness by removing keratin and increasing moisture | |
CN115137667A (en) | Cosmetic composition with permeation promoting effect and application thereof | |
CN112891248A (en) | Water-oil insoluble ceramide transparent oil solution and preparation method thereof | |
KR102100820B1 (en) | Rosa centifolia flower petal fermented by aureobasidium pullulans | |
CN112190576A (en) | Composition of skin external preparation, skin external preparation and preparation method thereof | |
KR100306847B1 (en) | Cosmetic composition for whole body | |
KR100737391B1 (en) | Nano particle composition comprising the aloe gel and cosmetics containing the same | |
KR101557422B1 (en) | Cleansing composition and cosmetic composition with the extract of Styrax japonica | |
CN112891270B (en) | Cosmetic composition and preparation method and application thereof | |
KR102656826B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Opuntia Tuna Fruit, Thuja Occidentalis Leaf and Lilium Candidum Bulb | |
JPS63227512A (en) | Cosmetic containing extract of tremella fuciformis | |
KR20220036434A (en) | Cosmetic composition containing fermented water-soluble chitosan having low molecular weight |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001932343 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018091652 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10276176 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001932343 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001932343 Country of ref document: EP |